FDA approves Boehringer’s Ofev to treat idiopathic pulmonary fibrosis
Ofev is a kinase inhibitor that blocks multiple pathways that may be involved in the scarring of lung tissue and these capsules will be available to patients within
Life science tools and diagnostics provider Bio-Techne Corporation has opened a new manufacturing facility in Bristol, UK, dedicated to good manufacturing practice (GMP) grade small molecules.
The results show that AG014 is safe and well tolerated while providing localized gastro-intestinal (GI) exposure. AG014 is the company’s ActoBiotics delivery platform and works by expressing and
Data from this randomized, double-blind, placebo-controlled, cross-over study demonstrated that duvelisib was well tolerated and met several secondary and exploratory endpoints in an allergen challenge study. Clinical improvement
Discovered and developed by Eisai, lenvatinib is an oral multiple receptor tyrosine kinase inhibitor with a unique binding mode that selectively inhibits the kinase activities of vascular endothelial